Search results
2 new COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 2 days agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
There's a new highly transmissible COVID-19 variant. Could FLiRT lead to a summer uptick?
Los Angeles Times· 3 hours agoTwo new COVID-19 subvariants, collectively nicknamed FLiRT, are increasingly edging out the winter’s...
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 4 days agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
How antibody levels can predict which children will outgrow their peanut allergy
Medical Xpress· 24 hours agoThe research, led by Murdoch Children's Research Institute (MCRI) in Melbourne and published in...
Immunovia Publishes Interim Report for January-March 2024
FOX 23 News Albany· 2 weeks agoOn April 9, the Company announced that Immunovia had successfully developed accurate and precise...
Labcorp gains FDA approval for hemophilia B diagnostic test By Investing.com
Investing.com· 1 week agoLabcorp (NYSE: LH) has announced the FDA approval of its nAbCyte Anti-AAVRh74var HB-FE Assay, a...
Celebrity News | Entertainment News | TMZ.com
TMZ· 7 hours agoArticles - October, 2020 Rep. Dwight Evans Says Trump Lost Pennsylvania with Philly 'Bad Things' Diss Jay-Z & Meek Mill's REFORM Alliance Scores Major Victory in California Chrissy Teigen and John Legend Lose Third
Missing Teeth and Joint Pain? RA May Be Imminent
MedPage Today· 1 week agoAmong 700 patients with "clinically suspect arthralgia," those having previous tooth extractions and positive tests for anti-citrullinated protein...
What are the new COVID FLiRT variants, and are they in Wisconsin?
Gannett via AOL· 2 days agoSymptoms may appear two to 14 days after exposure. Latest COVID guidance from the CDC In March 2024,...
OPKO Health Inc (OPK) Q1 2024 Earnings Call Transcript Highlight
Guru Focus· 4 days agoAsset Sale: Agreement to sell Bio-Reference health assets to LabCorp for $237.5 million.Revenue: Q1 2024 revenue for Diagnostics segment reported at $126.9 mil